SKI Market

Indian Indices

Nifty

24,833.60 81.15
(0.33%)

Sensex

81,633.02 320.70
( 0.39%)

Bank Nifty

55,546.05 129.05
( 0.23%)

Nifty IT

37,754.15 288.40
( 0.77%)

Global Indices

Nasdaq

42,126.73 -237.92
(-0.56%)

Dow Jones

5,911.18 -31.36
(-0.53%)

Hang Seng

38,404.78 682.38
(1.81%)

Nikkei 225

8,726.01 -52.04
(-0.59%)

Forex

USD-INR

85.30 0.19
(0.23%)

EUR-INR

96.87 0.16
(0.16%)

GBP-INR

115.48 0.30
(0.26%)

JPY-INR

0.59 0.00
(-0.55%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Lyka Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500259

INE933A01014

37.8089101

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYKALABS

49.96

411.86

EPS(TTM)

Face Value()

Div & Yield %

2.31

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	106.40	80.59	164.35	62.26	40.74	41.18
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	106.40	80.59	164.35	62.26	40.74	41.18
Other Income	1.65	3.45	2.72	2.21	4.34	2.58
Stock Adjustments	0.79	1.21	0.40	-2.04	0.28	-0.60
Total Income	108.84	85.25	167.47	62.43	45.36	43.16
EXPENDITURE :
Raw Materials	43.73	30.27	31.27	21.48	21.30	21.64
Power & Fuel Cost	3.92	3.57	3.88	2.91	2.52	2.22
Employee Cost	26.01	17.48	16.22	13.03	11.71	9.99
Other Manufacturing Expenses	2.53	2.81	2.25	2.27	1.40	1.05
Selling & Administrative Expenses	15.23	11.18	12.04	5.63	5.43	4.13
Miscellaneous Expenses	1.26	8.06	6.26	1.91	31.38	1.05
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	92.68	73.37	71.93	47.22	73.74	40.08
Operating Profit	16.15	11.88	95.55	15.20	-28.37	3.07
Interest	4.80	11.57	19.92	25.55	19.01	5.73
Gross Profit	11.35	0.31	75.63	-10.35	-47.38	-2.66
Depreciation	12.29	13.52	15.39	8.05	7.77	4.44
Profit Before Tax	-0.94	-13.21	60.24	-18.40	-55.15	-7.10
Tax	1.60	0.21	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.26	-0.13	20.34	-3.94	0.24	-8.83
Reported Net Profit	-2.27	-13.29	39.90	-14.46	-55.39	1.73
Extraordinary Items	0.04	-7.06	-3.09	-1.43	-27.63	-0.53
Adjusted Net Profit	-2.31	-6.23	42.99	-13.03	-27.76	2.26
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	-0.27
P & L Balance brought forward	-101.38	-88.09	-127.99	-113.54	-58.15	-36.76
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-103.65	-101.38	-88.09	-127.99	-113.54	-35.29
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-0.69	-4.33	13.91	-5.04	-19.31	0.62
Earnings Per Share(Adj)-Unit Curr	-0.69	-4.33	13.91	-5.04	-19.31	0.62
Book Value-Unit Curr	27.28	19.22	15.49	1.54	6.55	34.77
Book Value(Adj)-Unit Curr	27.28	19.22	15.49	1.54	6.55	34.77

24,833.60 81.15 (0.33%)

81,633.02 320.70 ( 0.39%)

55,546.05 129.05 ( 0.23%)

37,754.15 288.40 ( 0.77%)

42,126.73 -237.92 (-0.56%)

5,911.18 -31.36 (-0.53%)

38,404.78 682.38 (1.81%)

8,726.01 -52.04 (-0.59%)

85.30 0.19 (0.23%)

96.87 0.16 (0.16%)

115.48 0.30 (0.26%)

0.59 0.00 (-0.55%)